Three more people have become seriously ill after being sold rogue drugs at a music festival, just a day after a teenager died.
Christian Pay, 18, died following "substance abuse" at Kendal Calling music festival in the Lake District, Cumbria.
Since his death seven people have been treated in hospital, including a 29-year-old man who remains in a critical state and four people who are in "serious but stable" conditions.
Police urged people not to take drugs at the festival because of the safety risks. . Four people arrested on suspicion of possession with intent to supply have been released on bail.
A mass inhalation of "hippy crack" was carried out in the shadow of Parliament on Saturday in protest at the Government's drug policy.Read the full story ›
Smoking cannabis may stunt growth and trigger early puberty in boys, new research has revealed.Read the full story ›
An expert on addiction has said that prescribing heroin to addicts could be cheaper than methadone.Read the full story ›
Ireland has passed an emergency drug law to close legal loophole which meant it was legal to possess drugs such as ecstasy.
The Irish parliament's passed an emergency law after other drugs in the same class including ketamine and crystal meth became legal on Tuesday after a court challenge. The new legislation was officially be signed into law this afternoon, and comes into force at midnight
A drone attempting to fly crystal meth across the border to US drug dealers has crashed in Mexico.Read the full story ›
The first mobile drug-testing kit has been approved by the government as part of a crackdown on drug driving.
Called Drugwipe, it is the first portable device that can detect the presence of cannabis and cocaine, two of the most common substances used by drug drivers, by analysing a small quantity of saliva.
Results are indicated by the appearance of lines on the device - similar to a pregnancy test - within eight minutes.
Following a positive reading, the police will take the individual to the police station for a blood sample, which will be used in any subsequent prosecution.
The penalty under the new drug offence will be 12 months disqualification, a fine up to £5,000 and up to six months in prison or both.
The policing minister has said new plans to test drivers for drugs will "drive this menace off the road".
This is something that has plagued society for far too long.
People will have exactly the same view of drug-driving as they do of drink-driving: it is an abhorrent thing to do.
Not only do you put your own life at risk, but you put innocent people's lives at risk.
We will drive this menace off the road.
The Christmas and New Year holiday season will see drivers stopped by police and tested for drugs by the side of the road in a war on drug-driving.
The Telegraph has reported that the Home Office approved roadside testing kits that will analyse samples of saliva instantly to detect illegal substances as well as so-called "legal highs".
It said that police officers will also use the kits to catch drivers who have taken prescription medicines like strong painkillers, sleeping pills and drugs to treat anxiety, that can hinder concentration on the road.
It has been reported that ministers will order police to carry the "drugalyser" kits alongside conventional "breathalysers", which test motorists for alcohol consumption.
Officials said the review would examine how precision medicine and digital health technology could enable new products to be brought from the laboratory "as quickly and safely possible".
"This will transform the landscape of drug development from the 20th-century model to a world century model to a world in which the NHS becomes a partner in innovative testing, proving and adopting new drugs and devices in research studies with real patients," Mr Freeman told The Times.
"For too long NHS patients have seen drugs and innovations developed in the UK but not adopted here in our NHS.
"We are determined to unlock the power of our NHS to be a test-bed for the 21st-century medical innovations we all need, getting NHS patients faster access, reducing the cost of drug development and boosting our life science sector."